January 22, 2020

White paper: beyond the promise of artificial intelligence in electronic benefit verification

By Lash Group

AI-powered electronic benefit verification (eBV) represents a potent mix of human and technology that could positively impact every stakeholder in pharma. Manufacturers who make the most of that balance will have the competitive advantage.

Download our new white paper to learn how to optimize eBV with AI and machine learning.
Our white paper covers:
- The difference between logic-based and AI-based approaches for benefit verification
- Technologies that push what's possible for eBV
- How to evaluate and scale potential solutions for your unique needs

Enter Your Information to Access the White Paper

                                                First Name
    Last Name
    Company
    Email Address
    Title
Country*



    By submitting this form, I hereby consent to the receipt of marketing materials from
AmerisourceBergen and its affiliates via email and other forms of communications.

Topics:

Commercialization Patient support services Product access Technology